Porton Pharma Solutions Ltd. (300363.SZ)
CNY 17.08
(0.59%)
CNY 17.08
(0.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.2 Billion CNY | 139.18% |
| 2022 | 923.76 Million CNY | 24.7% |
| 2021 | 740.77 Million CNY | 79.52% |
| 2020 | 412.64 Million CNY | 18.79% |
| 2019 | 347.37 Million CNY | -69.88% |
| 2018 | 1.15 Billion CNY | 20.37% |
| 2017 | 957.99 Million CNY | -7.85% |
| 2016 | 1.03 Billion CNY | 33.39% |
| 2015 | 779.41 Million CNY | 66.23% |
| 2014 | 468.88 Million CNY | 108.02% |
| 2013 | 225.4 Million CNY | 14.58% |
| 2012 | 196.73 Million CNY | 32.58% |
| 2011 | 148.38 Million CNY | 13.61% |
| 2010 | 130.6 Million CNY | 43.16% |
| 2009 | 91.23 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.2 Billion CNY | 0.56% |
| 2024 Q1 | 2.19 Billion CNY | -0.68% |
| 2024 Q3 | 1.07 Billion CNY | -24.56% |
| 2023 Q4 | 2.2 Billion CNY | 65.47% |
| 2023 FY | 2.2 Billion CNY | 139.18% |
| 2023 Q3 | 1.33 Billion CNY | 0.41% |
| 2023 Q2 | 1.32 Billion CNY | 16.47% |
| 2023 Q1 | 1.14 Billion CNY | 23.6% |
| 2022 Q2 | 1.11 Billion CNY | 12.22% |
| 2022 Q1 | 993.8 Million CNY | 34.16% |
| 2022 FY | 923.76 Million CNY | 24.7% |
| 2022 Q4 | 923.76 Million CNY | -13.01% |
| 2022 Q3 | 1.06 Billion CNY | -4.79% |
| 2021 Q3 | 549.55 Million CNY | 15.18% |
| 2021 Q1 | 473.93 Million CNY | 14.85% |
| 2021 FY | 740.77 Million CNY | 79.52% |
| 2021 Q4 | 740.77 Million CNY | 34.79% |
| 2021 Q2 | 477.11 Million CNY | 0.67% |
| 2020 Q2 | 417.74 Million CNY | 2.3% |
| 2020 FY | 412.64 Million CNY | 18.79% |
| 2020 Q4 | 412.64 Million CNY | -5.77% |
| 2020 Q3 | 437.93 Million CNY | 4.83% |
| 2020 Q1 | 408.34 Million CNY | 17.55% |
| 2019 Q1 | 1 Billion CNY | -12.91% |
| 2019 Q3 | 555.54 Million CNY | -22.24% |
| 2019 FY | 347.37 Million CNY | -69.88% |
| 2019 Q4 | 347.37 Million CNY | -37.47% |
| 2019 Q2 | 714.42 Million CNY | -28.86% |
| 2018 Q4 | 1.15 Billion CNY | 3.58% |
| 2018 Q3 | 1.11 Billion CNY | -14.44% |
| 2018 Q2 | 1.3 Billion CNY | 40.58% |
| 2018 Q1 | 925.53 Million CNY | -3.39% |
| 2018 FY | 1.15 Billion CNY | 20.37% |
| 2017 Q2 | 910.97 Million CNY | -23.61% |
| 2017 Q1 | 1.19 Billion CNY | 14.71% |
| 2017 FY | 957.99 Million CNY | -7.85% |
| 2017 Q4 | 957.99 Million CNY | 15.46% |
| 2017 Q3 | 829.71 Million CNY | -8.92% |
| 2016 Q1 | 794.28 Million CNY | 1.91% |
| 2016 Q2 | 905.25 Million CNY | 13.97% |
| 2016 Q3 | 899.76 Million CNY | -0.61% |
| 2016 FY | 1.03 Billion CNY | 33.39% |
| 2016 Q4 | 1.03 Billion CNY | 15.54% |
| 2015 FY | 779.41 Million CNY | 66.23% |
| 2015 Q4 | 779.41 Million CNY | 3.78% |
| 2015 Q3 | 751 Million CNY | 28.25% |
| 2015 Q2 | 585.56 Million CNY | 16.81% |
| 2015 Q1 | 501.3 Million CNY | 6.91% |
| 2014 Q4 | 468.88 Million CNY | 15.09% |
| 2014 Q3 | 407.41 Million CNY | 28.04% |
| 2014 FY | 468.88 Million CNY | 108.02% |
| 2014 Q2 | 318.19 Million CNY | 14.04% |
| 2014 Q1 | 279.02 Million CNY | 23.79% |
| 2013 FY | 225.4 Million CNY | 14.58% |
| 2013 Q4 | 225.4 Million CNY | 0.0% |
| 2013 Q2 | 166.67 Million CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | 196.73 Million CNY | 32.58% |
| 2011 FY | 148.38 Million CNY | 13.61% |
| 2010 FY | 130.6 Million CNY | 43.16% |
| 2009 FY | 91.23 Million CNY | 0.0% |